Australia markets closed

Rhythm Biosciences Limited (RHY.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
0.08400.0000 (0.00%)
At close: 03:58PM AEST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
30/06/2023
30/06/2022
30/06/2021
30/06/2020
Operating expenses
Research development
3,648
3,648
5,159
4,555
1,939
Selling general and administrative
7,506
7,506
5,895
3,028
2,039
Total operating expenses
11,542
11,542
11,246
7,733
4,161
Operating income or loss
-11,542
-11,542
-11,246
-7,733
-4,161
Interest expense
-
-
-
0.396
7.796
Total other income/expenses net
3,096
3,096
2,427
1,109
100
Income before tax
-8,218
-8,218
-8,794
-6,612
-4,023
Income tax expense
0
0
0
0
0
Income from continuing operations
-8,218
-8,218
-8,794
-6,612
-4,023
Net income
-8,218
-8,218
-8,794
-6,612
-4,023
Net income available to common shareholders
-8,218
-8,218
-8,794
-6,612
-4,023
Basic EPS
-0.04
-0.04
-0.04
-0.03
-0.03
Diluted EPS
-0.04
-0.04
-0.04
-0.03
-0.03
Basic average shares
215,220
221,542
214,445
189,948
117,926
Diluted average shares
215,220
221,542
214,445
189,948
117,926